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Abstract. In previous work, a mobile application for medication self-management 
(eMMA) was introduced. It contained a basic conversational user interface (CUI). 
In this work, we extended the CUI by integrating the chatbot framework RiveScript 
and an instruction interface. To study task success, dialog quality and efficiency, we 
performed a theoretical and a quantitative evaluation as well as a usability test. The 
results show that the technical extensions of eMMA were useful to improve the 
chatbot's quality. However, the underlying knowledge base still requires substantial 
extensions before the system can be used in practice. 
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1. Introduction 
Many mobile applications exist for patients managing their prescribed medication. 
Within the “Hospital of the Future live” Project [1], the mobile application eMMA 
(referred to as eMMA 1.0) was introduced as an electronic medication management 
assistant for persons prescribed to medications within an age range between 18 and 85 
[2]. The goal was to address the problems of improving patient’s medication adherence 
and communicating medication data with health care providers, as well as serving 
patients as an educational source for drug information. Unlike other electronical 
medication diaries, eMMA uses a standardized format for medication data and is built 
with a conversational user interface (CUI) to simulate the interaction with a human 
assistant. A CUI is not only expected to be handled easier by elderly people, the 
assumption is that the illusion of interacting with an actual assistant could also improve 
medication adherence. eMMA 1.0 relied on a CUI with restricted knowledge base, only 
able to respond to several key words and a selection of drug names [2]. In this paper, we 
describe the extension of eMMA’s CUI by integrating a rule-based chatbot engine and 
an extended knowledge base (referred to as eMMA 2.0) for improving the quality of the 
CUI. Furthermore, we conducted a three-stage analysis for evaluating these extensions. 
This analysis consists of a theoretical analysis using a feature checklist, a quantitative 
analysis evaluating chatlogs from test persons using eMMA 2.0 and a usability test.  
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2. Methods 
2.1. Chatbot implementation 
To decide on a technology stack, different chatbot frameworks were evaluated. Criteria 
for the evaluation included: the capabilities of the chatbot service (in particular the ability 
of handling conversation context), the possibility of integrating it into eMMA 1.0 and 
the ability of working with medication data. Services running on external servers were 
excluded to ensure data privacy and continuous availability. Once a chatbot engine was 
chosen, the corresponding rule set that defines the system’s knowledge base was defined. 
For this purpose, first user tests with six test persons, recruited from the author’s personal 
background, were conducted, to clarify the weaknesses of the CUI of eMMA 1.0. All 
test persons had already made first experiences in using chatbots. In additional iterations, 
the rule set was extended.  
2.2. Chatbot evaluation 
The chatbot was evaluated in three stages. First, a theoretical analysis using the TRINDI 
framework was made to get a benchmark of the enhanced CUI. TRINDI is a checklist 
comprising 3 groups with 16 questions addressing a dialog-based system’s competences 
[3]. The first group (9 questions) refer to the flexibility in dialogue handling. The second 
group (5 questions), addresses the overall functionality of the system. The third group (2 
questions) deals with the system’s ability of context awareness. The checklist was 
independently filled out by two of the authors, with the answering options of “yes”, 
“partially”, “in theory”, “no” and “unknown”, as suggested by [3]. The resulting check-
lists where compared, and divergences were discussed until consent was achieved.  
 For the quantitative analysis, eight logs from eMMA 2.0 were compared to five logs 
from the tests with eMMA 1.0, where one log was lost due to technical problems. The 
analysis was done along the categories suggested from the PARADISE framework [4], 
namely task success, dialogue efficiency, dialog quality and user satisfaction. While user 
satisfaction was measured by a questionnaire accompanying the usability tests, the other 
categories could be derived from transcribed conversation logs. In order to analyze task 
success, individual tasks were identified in the logs and graded successful (coded TRUE) 
or unsuccessful (coded FALSE). For dialog efficiency, the number of dialogue steps used 
to complete such a task was counted. Dialog quality was measured by two variables: 1) 
the systems answering time, and 2) the adequacy of the systems immediate reply.  
Furthermore, a usability test of the CUI of eMMA 2.0 was conducted with a sample 
of eight test persons. Since these test persons were not prescribed to medications at the 
time of the test, a scenario was created for getting them in a context where a medication 
management assistant is applicable. For surveying and comparing user satisfaction 
among the two versions of eMMA, the questionnaire from the usability test of eMMA 
1.0 was used, consisting of 12 questions that were answered on a Likert scale from -2 to 
+2. Thus, the questionnaire could be completed within a range from -24 to +24 points. 
 To put the results from the quantitative analysis into context, the test persons 
additionally answered a short survey to what extend they would tolerate the lack of task 
success, dialog efficiency and dialog quality from a chatbot in a medical context like 
eMMA. 
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3. Results 
3.1. Implementation 
The chatbot framework RiveScript was chosen for reasons of privacy, ease of 
implementation and availability of German language foundations. It was included into 
eMMA 2.0 using the RiveScript 1.19 node module as an interpreter, running directly on 
the device. This interpreter module works as a black box, generating an answer to a user 
utterance, based on multiple rules specified in RiveScript files. The knowledge base of 
eMMA 2.0 was built on multiple pillars: First, basic German language understanding 
was added by a static script from the ALICE chatbot [5]. The file written in AIML could 
be translated into RiveScript syntax and had to be adapted to be adequate for the context. 
Answering patterns with medication context were included in another RiveScript file, 
context-awareness in mind. These patterns are based on the knowledge of eMMA 1.0, 
but also include results from the first usability tests and were improved iteratively during 
the entire development process. The Specialty List (http://www.spezialitaeten-liste.ch), 
a list containing all drug names of approved medications in Switzerland, was parsed to 
the RiveScript syntax and imported into the chatbot as external knowledge.  
Since the RiveScript interpreter has no direct access to the application’s memory, a 
dynamic context file is generated at every launch of the chatbot service, containing for 
example the user’s medication or the name of the general practitioner. Additionally, we 
implemented an instruction interface that allows the chatbot to control the application 
through the interpreter. Specific keywords in the returned text string are caught before 
the answer is displayed to the user and trigger the corresponding action, e.g. displaying 
the user YES / NO buttons instead of a free text answering field. Other use cases for the 
instruction interface are adding a medication to the plan or looking up medication details 
online. With dynamically generated RiveScript rule files and the instruction interface, 
we enabled a two-way communication between the application and the black-boxed 
RiveScript interpreter. 
3.2. Evaluation results  
The theoretical analysis with the TRINDI checklist shows that the implemented chatbot 
still has room for improvement. None of the sixteen checklist items could be answered 
with yes, five points are fulfilled partially. Four other features were assessed with 
theoretically, meaning that the RiveScript syntax would enable them, but not the current 
implementation. The remaining checklist items were evaluated with no (see Table 1). 
The most important failed item is if the system checks its understanding of the user’s 
utterance and can thus react accordingly. 
Table 1. Evaluation results of the TRINDI categories 
 Flexibility Overall functionality Context awareness 
Yes 0 0 0 
Partially 2 1 0 
Theoretically 4 1 1 
No 3 3 1 
Total 9 5 2 
As Table 2 shows, task success and the adequacy aspect of dialog quality were improved 
within eMMA 2.0. The slightly slower response time can be explained by the more 
complex pattern matching given the extended rule base. The average number of steps to 
G.I. Hess et al. / Improving and Evaluating eMMA’s Communication Skills 103
complete a task went up within eMMA 2.0. Contrary to expectations, eMMA 1.0 
achieved a slightly better user satisfaction, although both versions are in the center of the 
scale ranging from -24 to 24. The usability test showed that users were able to interact 
with eMMA 2.0 and successfully finish complex tasks that need to hold the conversation 
context over several messages. 
Table 2. Results of the quantitative evaluation 
 Task  
success 
Dialog  
efficiency 
Dialog quality
(response time) 
Dialog quality 
(adequacy) 
User 
satisfaction 
eMMA 1.0 7.7% 5.3 steps 20 ms 16.9% 2.6 pt 
eMMA 2.0 62.4% 9.7 steps 20 – 50 ms 59.3% -3.3 pt 
For context, we asked our test persons in the usability test what percentages of task 
success or dialog efficiency and quality they would consider acceptable. The resulting 
84.2% for task success and 74% of dialog adequacy could not been reached by either of 
the evaluated versions. Also, the regarded acceptable number of steps of four for a simple 
and up to 9.5 for a complex task was missed by eMMA 2.0. Unaltered response time was 
in the range of milliseconds for both versions. Early usability tests showed that these are 
considered too fast, leading the original developers of eMMA 1.0 to artificially slow 
down the answering speed to the scale of seconds, which was kept for eMMA 2.0.  
4. Discussion 
In this paper, we introduced a rule-based chatbot to enhance the CUI of an existing 
medication management application by internal and external context information. The 
technical extensions led to better values in task success as well as in dialog quality. It 
turned out that the extended ability for more complex tasks led to a poorer dialog 
efficiency. To address this, graphical user interface elements could be contextually 
brought up inside the CUI for quicker handling of complex tasks. In general, the 
evaluations and user test shows, that, besides fixing technical bugs, the eMMA 2.0 
chatbot still needs an enhanced knowledge base and a better context management. This 
can be achieved with the existing technology stack, but needs massive enhancement of 
the RiveScript rule files, based on more conversation logs and possibly assisted by 
machine learning. The introduced instruction interface could also be used to implement 
a function that allows the chatbot react adequately when it can’t understand a user’s 
utterance. Once these extensions have been realized, eMMA 2.0 will have the potential 
of being released on the market. 
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